Tech Company Financing Transactions

Afferent Pharmaceuticals Funding Round

On 12/16/2009, Afferent Pharmaceuticals raised $23 million in Series A financing from Pappas Ventures, Third Rock Ventures and Domain Associates.

Transaction Overview

Company Name
Afferent Pharmaceuticals
Announced On
12/16/2009
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series A
Investors

Pappas Ventures (Lead Investor) (Arthur Pappas)

Third Rock Ventures (Lead Investor) (Kevin Starr)

Domain Associates (Jesse Treu)

New Leaf Venture Partners (Liam Ratcliffe)

Proceeds Purpose
Proceeds from the financing will be used toaccelerate the development of P2X3 receptor targeted pain therapies.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2755 Campus Dr. 100
San Mateo, CA 94403
USA
Phone
(650) 286-1276
Website
www.afferentpharma.com
Email Address
Not Recorded
Overview
A leader in the development of novel, selective small molecules that target the P2X3 purinergic receptor, for the treatment of a range of debilitating symptoms and sensory disorders.
Profile
Afferent Pharmaceuticals LinkedIn Company Profile
Social Media
Afferent Pharmaceuticals Company Twitter Account
Company News
Afferent Pharmaceuticals News
Facebook
Afferent Pharmaceuticals on Facebook
YouTube
Afferent Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kathleen Glaub
  Kathleen Glaub LinkedIn Profile  Kathleen Glaub Twitter Account  Kathleen Glaub News  Kathleen Glaub on Facebook
Chief Medical Officer
Michael Kitt
  Michael Kitt LinkedIn Profile  Michael Kitt Twitter Account  Michael Kitt News  Michael Kitt on Facebook
Chief Scientific Officer
Anthony Ford
  Anthony Ford LinkedIn Profile  Anthony Ford Twitter Account  Anthony Ford News  Anthony Ford on Facebook
VP - Operations
Peter Butera
  Peter Butera LinkedIn Profile  Peter Butera Twitter Account  Peter Butera News  Peter Butera on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/16/2009: Jinni venture capital transaction
Next: 12/16/2009: Wealthfront venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to document tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.